---
figid: PMC6186589__jtd-10-S26-S3186-f1
figlink: /pmc/articles/PMC6186589/figure/f1/
number: F1
caption: 'A schema of sortilin regulating EGFR trafficking (). Sortilin is mainly
  localized at the plasma membrane and the trans-Golgi network (TGN). (A) Endocytosis:
  under normal circumstances, sortilin is essential for EGFR sorting in EGFR endocytosis
  (B) Exocytosis: upon ligand binding, cell surface EGFRs are activated and internalized,
  and then either sorted at the early endosome (EE) or cycled continually between
  the surface of plasma membrane and the TGN via endocytosis and exocytosis. (C) EGFR
  signaling: the most known EGFR ligand is EGF, which activates the phosphorylation
  of EGFR tyrosine kinases and downstream signaling pathways, including the Ras/Raf/MEK-ERK/MAP
  kinase, PI3K/AKT/mTOR, and JAK/STAT pathways, for cell growth, survival, migration,
  anti-apoptosis, and promoting angiogenesis. Loss of sortilin expression results
  in failure of EGFR receptor internalization which leads to prolonged or continuous
  activation of EGFR signaling cascade, enhanced cell proliferation and/or survival,
  invasion, metastasis, and poor clinical outcomes. The fate of EGFR has important
  consequences for biological cell outputs: the recycling pathway favoring cell proliferation
  while the degradative pathway controlling normal cellular homeostasis. Several reported
  key regulators for each process were listed within this figure (). Additionally,
  EGFR may translocate to the nucleus and mitochondria although the transport mechanisms
  remain to be elucidated. EGF, epidermal growth factor; EGFR, epidermal growth factor
  receptor; ESCRT, endosomal sorting complex required for transport; MVBs, multivesicular
  bodies; TGN, the trans-Golgi network.'
pmcid: PMC6186589
papertitle: Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming
  resistance to EGFR inhibitors in non-small cell lung cancer.
reftext: Qianping Li, et al. J Thorac Dis. 2018 Sep;10(Suppl 26):S3186-S3191.
pmc_ranked_result_index: '94244'
pathway_score: 0.804992
filename: jtd-10-S26-S3186-f1.jpg
figtitle: Schema of sortilin regulating EGFR trafficking ()
year: '2018'
organisms: Homo sapiens
ndex: 113333a4-df2a-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6186589__jtd-10-S26-S3186-f1.html
  '@type': Dataset
  description: 'A schema of sortilin regulating EGFR trafficking (). Sortilin is mainly
    localized at the plasma membrane and the trans-Golgi network (TGN). (A) Endocytosis:
    under normal circumstances, sortilin is essential for EGFR sorting in EGFR endocytosis
    (B) Exocytosis: upon ligand binding, cell surface EGFRs are activated and internalized,
    and then either sorted at the early endosome (EE) or cycled continually between
    the surface of plasma membrane and the TGN via endocytosis and exocytosis. (C)
    EGFR signaling: the most known EGFR ligand is EGF, which activates the phosphorylation
    of EGFR tyrosine kinases and downstream signaling pathways, including the Ras/Raf/MEK-ERK/MAP
    kinase, PI3K/AKT/mTOR, and JAK/STAT pathways, for cell growth, survival, migration,
    anti-apoptosis, and promoting angiogenesis. Loss of sortilin expression results
    in failure of EGFR receptor internalization which leads to prolonged or continuous
    activation of EGFR signaling cascade, enhanced cell proliferation and/or survival,
    invasion, metastasis, and poor clinical outcomes. The fate of EGFR has important
    consequences for biological cell outputs: the recycling pathway favoring cell
    proliferation while the degradative pathway controlling normal cellular homeostasis.
    Several reported key regulators for each process were listed within this figure
    (). Additionally, EGFR may translocate to the nucleus and mitochondria although
    the transport mechanisms remain to be elucidated. EGF, epidermal growth factor;
    EGFR, epidermal growth factor receptor; ESCRT, endosomal sorting complex required
    for transport; MVBs, multivesicular bodies; TGN, the trans-Golgi network.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CAMLG
  - EPS15
  - AKT1
  - AKT3
  - TNS4
  - STAT6
  - MAPK3
  - AKT2
  - EGFR
  - RAB35
  - ARAF
  - RAF1
  - STAT5A
  - PIK3R6
  - PIK3R5
  - AGR2
  - PIK3CA
  - MAPK1
  - STAT5B
  - STAT1
  - PIK3R4
  - RAB4A
  - STAT4
  - JAK2
  - STAT2
  - STAT3
  - PIK3CB
  - TYK2
  - MAP2K2
  - BRAF
  - JAK3
  - NRAS
  - PIK3CD
  - MAP2K1
  - MTOR
  - PTS
  - ROR1
  - PIK3CG
  - JAK1
  - PIK3R3
  - RHOD
  - KRAS
  - HRAS
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: CAML,Eps15s,Odin
  symbol: CAML
  source: hgnc_alias_symbol
  hgnc_symbol: CAMLG
  entrez: '819'
- word: CAML,Eps15s,Odin
  symbol: EPS15
  source: hgnc_symbol
  hgnc_symbol: EPS15
  entrez: '2060'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: CTEN,
  symbol: CTEN
  source: hgnc_alias_symbol
  hgnc_symbol: TNS4
  entrez: '84951'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Rab4/Rab35,
  symbol: RAB35
  source: hgnc_symbol
  hgnc_symbol: RAB35
  entrez: '11021'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: thioredoxin,AGR2,
  symbol: AGR2
  source: hgnc_symbol
  hgnc_symbol: AGR2
  entrez: '10551'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Rab4/Rab35,
  symbol: RAB4
  source: hgnc_prev_symbol
  hgnc_symbol: RAB4A
  entrez: '5867'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PTPS,
  symbol: PTPS
  source: hgnc_alias_symbol
  hgnc_symbol: PTS
  entrez: '5805'
- word: ROR1,
  symbol: ROR1
  source: hgnc_symbol
  hgnc_symbol: ROR1
  entrez: '4919'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6186589__F1
redirect_from: /figures/PMC6186589__F1
figtype: Figure
---
